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The objective is to reveal the difficulties concerning the access and use of medicines by elderly individuals 
with dementia, reported by their caregivers. This qualitative study applied the participant observation 
method during pharmaceutical appointments performed in a specialized geriatrics service of the University 
Hospital of Brasília. Caregivers reported facing difficulties regarding the itinerary for medicines access 
in public pharmacies, as well as the high cost of these technologies in private establishments. Psychiatric 
symptoms, cognitive deficits, behavioral changes, apraxia, dysphagia, among other clinical manifestations 
of dementia syndromes, incapacitates the elderly for self-responsibility concerningthe use of drugs, 
which accentuates the complexity of medicines administration within the care process. In conclusion, 
it is fundamental to recognize caregivers’ role in promoting the rational use of medicines, and so this 
theme should be highlighted within the pharmaceutical services context.
Keywords: Elderly/dementia/care. Caregiver. Drugs/access. Rational use of medicines. Pharmaceutical 
services.
INTRODUCTION
The National Policy of the Elderly emphasizes that the 
presence of a functional disability in this group, regardless 
the origin of the disability, points to the need for a caregiver 
(Brasil, 2006). In this context, given the vulnerability 
situation and the progressive debilitation linked to the illness 
process, the importance of having a caregiver to elderly 
individuals with dementia is noteworthy.
In addition to presenting some restrictions due 
to typical physiological changes of both aging and 
comorbidities, this special population expresses cognitive 
deficits, decline in executive functioning, behavioral 
fluctuations and psychiatric symptoms. Such scenario 
explains the autonomy loss in the elderly, which 
consequently leads to dependence on the caregiver so as 
to perform usual daily living activities, including drug 
therapy compliance (Floriano et al., 2012; Del Duca, 
Martinez, Bastos, 2012).
Medicines constitute important health technologies, 
with multiple purposes as prevention of injuries; 
promotion, recovery and rehabilitation of health; and also 
the use for diagnostic purposes (Vieira, 2007). However, 
aside from the biomedical universe, medicines fulfill 
multiple meanings such as “object of adoration and iodine 
at the same time, the type of relationship that is established 
when an object is not indifferent” (Banõs-Diéz, Farré-
Albaladejo, 2002, p.272). Thus, medicines use acquires 
deep social meanings, as it ensures the elderly can live with 
dignity and quality of life, contributing also to his active 
aging process and higher life expectancy in the family 
core. Meanwhile, the symbolic dimension materializes 
the disease recognition and all responsibilities that the 
treatment assigns (Leite, Vasconcellos, 2008).
Monteschi, Vedana and Miasso (2010) have 
conducted a qualitative-quantitative research aiming to 
verify the degree of knowledge and related difficulties 
present in the drug therapy of the elderly with bipolar 
disorder. For this purpose, they interviewed the respective 
caregivers, who described the following drug therapy 
problems: patients non-adherence, overload of tasks 
related to drug therapy, inappropriate or ineffective 
treatment, concern about access to medicines, and patient’s 
alcohol intake.
Understanding the adversities in the context of 
elderly individuals with dementia care and recognizing 
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the background and experiences of both caregivers and 
patients compose essential factors to develop resolutive 
and humanized interventions regarding pharmaceutical 
services. Contributing to this debate, the present study 
aimed to reveal the obstacles related to access and use of 
medicines by elderly individuals with dementia, by their 
caregivers perspective.
MATERIAL AND METHODS
There are few studies focusing on understanding 
the routine of medicines usage in Brazil. Discussions 
regarding analysis of the dynamics of caregivers who 
provide home care to the elderly with dementia are even 
scarcer. In order to triangulate these two themes as the 
analysis object, we adopted the qualitative methodology 
in health, to better understand individual or collective 
meaning of drug therapy from the perspective of this 
cohort’s caregivers (Turato, 2005).
Nogueira-Martins and Bógus (2004) point out that 
interview, observation, and focus group, are the most 
employed techniques within qualitative methodology 
in health researches. Participant observation necessarily 
implies a long process, both for insertion and for 
experimentation in the field of research, making it 
possible to develop exploratory and continuous analysis 
of the subjects within a given scenario (Valladares, 2007). 
Thereby, we have selected this method to describe all 
the study´s reports and data. We undertook participant 
observation for a six-month period (July to December 
2013), through pharmaceutical appointments carried at 
the Multidisciplinar Elderly Center (MEC), located in the 
University Hospital of Brasília, Federal District.
This center (MEC) represents a reference service 
in the Federal District regarding the follow-up of elderly 
people with dementia, especially those diagnosed with 
Alzheimer’s disease. It started to operate in December 
2002 and stands out because of its assistance to the elderly 
being performed in an interdisciplinary and integral care 
perspective (Barros, 2014). 
During the research completion period, the service’s 
multiprofessional team - composed by professionals from 
the university hospital, besides professors, undergraduate 
and graduate students from University of Brasilia (UnB) 
- have counted on specialists of the following areas: 
Geriatrics, Pharmacy, Dentistry, Social work, Psychology, 
Nursing, Occupational therapy, and Physical therapy. 
To carry out participant observation, we followed 
Patton’s criteria described in the theoretical framework 
of Nogueira-Martins and Bógus (2004), as follows: i. 
Researcher ability to insert into the research environment 
(successive visits to the setting before the study period); 
ii. Interpersonal skills (incorporation and participation 
of the researcher in the care provided by the different 
team areas, articulating interpersonal relationships and 
socio-cultural insertion with professionals and users); 
and iii. Criteria and means for selecting the material to be 
registered (through a registration instrument based on field 
diary structure, as well as recording the pharmaceutical 
appointments’ audios).
Data were collected and recorded exclusively by the 
principal researcher, and pharmaceutical appointments 
were performed by a professor from UnB Pharmacy 
Faculty. This aimed to track patients with drug therapy 
issues and who should therefore be assisted by the 
multiprofessional team in a singular and integral way. 
Along these appointments, researcher has inquired 
participants about pertinent informations, seeking for an 
opportune moment to ask the survey questions. At this 
time, caregivers’ reports were explored so as to investigate 
the difficulties considering access and use of medicines by 
elderly individuals with dementia.
In addition to the researcher and the teacher, there 
were also in the appointment room two or three interns 
from the Pharmacy Faculty, as well as the elderly and his 
caregivers. Sometimes, information of up to four different 
caregivers were obtained in a single consultation. Study’s 
inclusion criteria included the following requirements: to 
be a caregiver of the elderly with a diagnosis of dementia; 
to be 18 years of age or older; and to be responsible for 
the correspondent medicines acquisition or administration. 
There was one patient whose diagnosis changed from 
Alzheimer´s disease to depression throughout the research 
period, for this reason her caregiver’s report was excluded 
from the study.
Information registered during data collection were 
transcribed and analyzed according to thematic analysis’ 
technique. Ideas within the statements of participants’ 
discourses originated the study units of meaning, which 
were organized by two researchers (experts in qualitative 
research) into categories of analysis, according to 
Oliveira’s study (2008).
This study was approved by the Research Ethics 
Committee of the Faculty of Health Sciences of University 
of Brasilia (protocol number 330.999), in accordance with 
Brazilian regulatory entities.
RESULTS AND DISCUSSION
Thirty-two pharmaceutical appointments were 
followed-up, totalizing 44 caregivers reports (more than 
one caregiver per patient). The sample description is 
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shown in Table I. Most caregivers were female (n = 36; 
81.0 %), were in the 40-59 age group (n = 21; 47.7 %), 
and were closely related to the patient (son or daughter) 
(n = 30; 68.1 %), similar data when compared to other 
studies embracing the elderly caregivers (Babarro et al., 
2004; Brodaty, 2009; Gaioli, Furegato, Santos, 2012).
The majority of respondents were classified as 
informal caregivers (n = 38; 86.4 %). In this category, 
we included family members who were in some way 
bonded with the patient, characterized by being, above 
all, volunteers who performed this function without 
specific professional training. The other six (13.6 %) were 
considered formal caregivers, which means they provided 
care for the elderly based on their occupation or specific 
training on caregiving.
Concerns raised by caregivers during pharmaceutical 
consultations were organized into the following categories 
of analysis: “access to medicines”, “drug therapy 
accountability “, and “drug therapy administration”.
Access to medicines
According to a national survey on the access, use, 
and promotion of the rational use of medicines, there have 
been significant advances in our country’s pharmaceutical 
services scenario (Tavares et al., 2016). Among them, the 
increasing access to medicines stands out, especially those 
to treat chronic non-communicable diseases, frequently 
used by the elderly population.
Despite aforementioned data, and taking into 
account that this picture does not fit generalizations due to 
the very nature of this qualitative study, it is not eworthy to 
consider the still existing access to medicines dilemma that 
permeates experiences of care. In this sense, caregivers 
reported the need to arrange exorbitant resources from 
the family income so as to afford the elderly drug therapy, 
as it follows: 
“...it’s getting tough now, this one is very expensive. 
Last month we spent US$ 870.00 and this month we´ve 
already spent US$ 430.00” (caregiver number 3).
This way, although socioeconomic policies have 
broadened participation of the Brazilian population 
into the consumer market in recent decades, access 
to health services and technologies remains unequal, 
directly affecting the quality of care for the elderly within 
domiciliary context (Machado, 2013).
Yap, Thirumoorthy and Kwan (2016) pointed the 
cost of drug therapy as a negative factor for adherence 
to treatment, particularly for the retired elderly or those 
with low-income -whose feeding and housing concerns 
are prior to purchasing medicines. Nonetheless, there 
are further family expenditures, such as other members’ 
medicines needs, which also burden the budget for the 
acquisition of health services and technologies. In one of 
pharmaceutical consultations, when questioned about the 
elderly’s access to medicines, a caregiver reported: 
“...well, when it comes to him, I tend to buy it all. We 
work it out, you know?But mine... The one for osteoporosis 
is expensive, it´s US$ 70.00... So we buy just his because 
it´s more serious” (caregiver number 6). 
This narrative approaches the discussion of an 
American study that revealed caregivers usually privilege 
TABLE I – Description of caregivers of elderly individuals with dementia assisted by MEC, December 2013
Variables Categories (n) (%)
Gender Female Male
36 
8
81.0 
19.0
Age group
20-39 years 
40-59 years 
≥ 60 years 
14 
21 
9
31.8 
47.7 
20.5
Caregiver-patient relationship 
nature
Partner 
Son / Daughter 
Daughter in law 
Sister 
Grand daughter 
Niece 
Professional
7 
30 
1 
3 
1 
1 
1
15.9 
68.1 
2.3 
6.8 
2.3 
2.3 
2.3
Caregiver origin Formal 
Informal
6 
38
13.6 
86.4
Total 44 100.0
MEC: Multiprofessional Elderly Center.
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the acquisition of the elderly treatment, underestimating 
their [caregivers] own adherence and use of medicines 
(Shrank et al., 2011).
In order to achieve access to medicines through 
Brazilian Public Health System (BPHS), caregivers 
expend multiple efforts in order to accomplish deadlines, 
to bring all necessary documents, and often to move from 
one to another establishment of pharmaceutical services 
network. There was this one caregiver who referred he 
could not get the elderly medicines in a public community 
pharmacy due to lack of information: 
“We are no longer providing this one. I’ll get 
information on 102 [address of a public establishment 
named Specialized Component of Pharmaceutical 
Assistance].... I got to go to HPAP [a mental health 
specialized hospital], ´cause the doctor told me it was 
there, but when I got there... They said it´s not here, it´s 
on 102. This doctor said it´s not, I don´t know. So I don´t 
know...” (caregiver number 5). 
Thus, health professionals’ orientations should also 
guide patients and their caregivers towards the effective 
route to access the respective medicines, instructing 
all about documents, deadlines, and other necessary 
procedures, according to inherent organizational 
specificities of each funding component and program 
concerning the local pharmaceutical services structure.
Access represents a valuable indicator for rational 
use of medicines (Ferreira et al., 2013).This parameter is 
likewise closely associated to the satisfaction degree of 
users with health services, as exemplified in the following 
speech:
“Galantamine, right? I´ve already tried to get 
it with the prescription, I tried it twice. But then the 
pharmacy attendance passwords end and next time the 
prescription loses its validity. And it´s also not always 
available [medicines]... Things are pretty difficult at 
the ‘high cost pharmacy’ [popular name for public 
community pharmacies within Specialized Component 
of Pharmaceutical Assistance context]. I went there about 
three times and I couldn´t get it. If we could, I’d rather not 
pay. In this case the best to do is just to buy it” (caregiver 
number 6).
From this caregiver’s point of view, his experience 
was a torment not only because of medicines shortage 
issue, but also due to the service’s operating logistic, 
which was not able to meet his demands. Ensuring the 
integrality principle for SUS users contemplates not only 
the availability of medicines, but is also about instructing 
them around pharmaceutical services modus operandi, 
and to promote these health technologies’ rational use by 
the elderly under supervised care. 
Drug therapy accountability
As for the elderly who present limitations in 
performing instrumental activities of daily living - among 
which are the ones involving medicines use (Viveiro et 
al., 2014) - it is crucial that the caregiver takes on the 
accountability for drug therapy. The elderly’s dependence 
on the caregiver with respect to the drug therapy 
management is linked, for instance, to memory loss, a 
common symptom present in dementia syndromes: 
“He [referring to the patient] forgot it once [to take 
the medicines], so the doctor told me to take care of it from 
now on” (caregiver number 1).
However, these same caregivers complained that 
all family members should share activities related to 
medicines use, so that to avoid overload and discontinuity 
in the care offered to the patient, as it may happen when 
tasks are strictly assigned to only one individual: 
“Look, I can´t do it by myself. When I’m home I 
give him the pills. But what about when I’m at work? The 
guys occasionally give it, but yet complain” (caregiver 
number 21). 
This approach highlights the need to enhance and 
strengthen the support network offered to the elderly, so 
that all caregivers embrace the assignments related to 
patient’s drug therapy, and lead them in a coherent way 
to reflect a collaborative, effective and safe management.
Considering the opposite circumstance, where 
caregivers were sharing the responsibility for drug 
therapy, new barriers emerged. The advantage of the 
main caregiver being less exposed to exhaustion in this 
situation is remarkable, since there is collaboration of 
other individuals in the process of care involving the use 
of medicines (Vieira et al., 2011). However, in some cases, 
the elderly may receive care differently by each caregiver 
given the absence of conduct standards, as observed in this 
interviewee’s report when asked about episodes involving 
missing doses: 
“At first, yes. He had gone to one’s place at the 
weekend, so he forgot about it in the morning and took it 
at night, when he was back home” (caregiver number 2). 
This way, even though health services empower 
the main caregiver in relation to safe and effective drug 
therapy management, it is vital that this protagonist 
disseminates acquired knowledge to all who will take 
part in the care, so as to ensure the quality throughout the 
process. 
The deficit in the level of self-awareness of disease, 
a phenomenon known as anosognosia, was recognized as a 
dementia syndromes’ typical symptom (Maki, Yamaguch, 
Yamaguch, 2013). In this context, the elderly individual 
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is not certain about diseases limitations and signs (Sousa 
et al., 2011), lacking therefore the perception of the need 
for treatment, as follows: 
“He [referring to the patient] no longer takes the 
medicine, he thinks he doesn’t need to... He forgot having 
labyrinthitis and stopped taking it. And when we say 
he must take it he says he has nothing. Sometimes he 
remembers having the disease, sometimes not” (caregiver 
number 25).
Thereby, besides tensing up family relationship - 
once patients with anosognosia are not able to identify 
their disabilities and failures, and generally react in a 
hostile manner when these are pointed out by family 
members (Maki, Yamaguch, Yamaguch, 2013) - it was 
also observed that this same phenomenon expands the 
need of caregivers to be responsible for the care and use 
of medicines by the elderly.
Deficits in cognitive function lead to memory loss in 
the elderly, reducing the capacity to remember taking the 
correct doses, and this aspect has already been mentioned 
in the literature as a limiting factor for treatment adherence 
(Yap, Thirumoorthy, Kwan, 2016): 
“Sometimes she [the elderly] forgets to take the 
evening dose. Or otherwise, when she says she has already 
taken, that means she took it twice” (caregiver number 15). 
This scenario may expose the elderly both to 
the risk of ineffectiveness of treatments used for the 
management of dementia and other diseases, as well 
as to drug intoxication. In addition to the forgetfulness 
component, elderly individuals with dementia present 
significant vulnerabilities that may arise from the complex 
polypharmacy phenomenon, which endorses the need 
for accountability by the caregiver (Maher-Júnior et al., 
2014):
“Our mom takes lots of pills. Now it´s around 20 per 
day! Can you imagine her, having a weak mind, and still 
taking it all by herself?”(caregiver number 9).
Drug therapy administration
Following the elderly diagnosis, family members 
retrace roles, functions and tasks to conciliate their daily 
life with the numerous activities regarding care provision. 
Still, it was observed that some caregivers had difficulties 
to effectively turn the administration of medicines into a 
habit (Smith et al., 2017; Aston et al., 2017): 
“...Things are complicated because I work and we´re 
still adjusting the medication. You see, for the person who 
works that is a change... Until you get organized... So right 
now things are pretty messy” (caregiver number 7).
There were cases in which caregivers could not 
conciliate formal employment with the care assignment, 
being common the decision to quit their jobs and abdicate 
their career so as to fully dedicate themselves to patient’s 
caregiving. This contributes to perpetuate the social 
stereotype of women as the main care provider (Pegoraro, 
Caldana, 2008): 
“Look, I tried to take care of everything... It was 
impossible... Imagine having to give 25 pills? Every 
single day? In addition to baths, food, changing diapers... 
Sometimes I think: I can’t handle it myself. There’s no way, 
I had to stop working…” (caregiver number 18).
About forgetting the dosage regimens, this aspect 
was also manifested by caregivers:
“Sometimes we forget it, but we don’t give it 
thereafter, we wait for the next scheduled dose” (caregiver 
number 25); “Oh yeah! Yes she’s taking… Hmm… My 
brain… Which one is it? Citalopram, risperidone, I 
forgot... I ended up forgetting because she recently started 
them, the first pill box has just ended... Sometimes I forget 
about the medicine, the things...” (caregiver number 37). 
Another study also discusses data regarding 
forgetfulness of medicines administration times by 
caregivers (Travis, Bethea, Winn, 2000), demonstrating 
the relevance of the pharmacist in proposing strategies 
and using resources to reinforce the memory and treatment 
adherence by these individuals.
Some caregivers mentioned making adjustments to 
the therapeutic scheme according to their perception of the 
patient’s health condition (Look, Stone, 2017): 
“At first the angiologist had also prescribed 
zolpidem... I think it was a big mistake, imagine a medicine 
that unbalances one’s mind... She just fell off the bed, and 
you had to hold her. I diluted it and threw it away. I used 
only one pill” (caregiver number 10); “I´ve decided on my 
ownto split it, because it was causing insomnia” (caregiver 
number 30). 
Practices like this, as dose adjustments, suspension, 
and introduction of medicines - as well as homemade 
remedies, are recurrent and on one hand may interfere 
with effectiveness and safety of drug therapy, and so 
health professionals tend to disapprove them. On the other 
hand, social anthropological literature conceives the term 
therapeutic itinerary as individuals or groups’ actions 
towards health recovery, which may mobilize different 
resources, including homemade remedies (Cabral et al., 
2011). The literature already addresses the theme of self-
adjustment of drug therapy by patients (Waheedi et al., 
2017; Kobue, Moch, Watermeyer, 2017, Laue, Melbye, 
Risør, 2017). However, few discussions address how this 
phenomenon occurs from caregivers perspective, which 
reinforces the importance of this study results.
D. S. L. Barros, D. L. M. Silva, S. N. Leite
Braz. J. Pharm. Sci. 2019;55:e17539Page 6 / 8
Psychiatric and behavioral symptoms related to 
clinical manifestation of dementia may increase the 
elderly intransigence at medicines administration moment 
(Gillespie et al., 2014):
“To take the medicine? He doesn’t want to, he doesn’t 
accept it. I put into his mouth but he holds it in his tooth. 
Then he says it’s gone. He has no difficulty in swallowing 
food, he’s just not accepting it” (caregiver number 9).
This complexity in adherence to drug treatment 
concerning the mental health field has been discussed 
in a study, evidencing that patient resistance results 
in abnormal medicines use (Cardoso, Galera, 2009). 
Consequently, the elderly’s health state may be impaired, 
exacerbating symptoms and recurrent hospital admissions.
Regarding parenteral pharmaceutical formulations, 
apraxia and painful perception related to the procedure 
constitute obstacles in administering these medicines in 
the elderly (Travis, Bethea, Winn, 2000): 
“…He [referring to the patient] must take both NPH 
and regular insulin. But he can no longer do the procedure 
by himself, and so I have to prick his skin. Even so, he 
complains that it hurts and doesn’t tolerate it. Sometimes 
he gets angry at me, like it’s my fault” (caregiver number 
8).
As a result, it is common for the elderly to become 
apprehensive by the time of the administration, especially 
with the assigned caregiver. 
Behavioral changes of the elderly impair their social 
life, mostly with family members who are more engaged 
to the care. The patient may behavior aggressively towards 
the caregiver (verbally or even physically), and this 
violence frame may get broader meanings that gradually 
deteriorate affective relationships. Patient’s violent 
attitude due to a disease can even reach the dimension of 
symbolic violence, in which the caregiver, over a dominant 
position within care relationship, legitimizes hostile acts 
in response to that initial impulse triggered by the elderly. 
A caregiver who referred to increase the sedative doses in 
an attempt to minimize interaction with the patient, thus 
mitigating existent conflicts, elucidates such situation.
Dysphagia is another frequent condition that 
accentuates the complexity care for the elderly with 
dementia, owing to the difficulty in swallowing oral 
medicines and food (Folle, 2012). In order to overcome 
this obstacle and assure the medicines administration, 
caregivers perform maceration and grinding of solid 
forms, which may interfere with biopharmaceutical 
aspects: 
“She can´t swallow the pill, it gets stuck in her 
throat. When it’s too big we split it” (caregiver number 11); 
“I let it in the water until it gets soft” (caregiver number 
23); “I crush it and put into water” (caregiver number 24); 
“I let it dissolving in water” (caregiver number 4). 
These strategies may impair the effectiveness and 
safety of the treatment, and so the pharmacist should 
plan interventions together with the multiprofessional 
team in order to select the most suitable pharmaceutical 
formulations to each patient, adding therefore to the 
rational use of medicines.
As illustrated, there are several experiences 
that depict difficulties in access and use of medicines 
according to the records provided by caregivers of the 
elderly with dementia. Nevertheless, most caregivers’ 
backgrounds compromise and have intersection with the 
adherence theme, reinforcing its multifactorial etiology 
and complexity in the care sphere.
In being responsible for the activities related to 
promote health and rational use of medicines in the 
elderly, the caregiver should be singularly reached 
by pharmaceutical actions involving care. However, 
it is worth noting the scarcity of studies that address 
the pharmacist’s importance in developing specific 
communication and interaction skills with caregivers, 
evidencing the need for further researches in the area.
Several of the abovementioned aspects and 
discussions were not completely investigated in similar 
studies, highlighting the importance and depth of our 
findings. However, it is imperative to expand research in 
this thematic, once the care dynamics rises new barriers 
that may hinder the supervision to be performed by the 
caregiver for elderly individuals with dementia.
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